MFVAX: Profile for MASSMUTUAL SELECT FOCUSED VALUE

Levy serves as partner, president, chief executive officer and portfolio manager with Harris Associates, his employer since 1985. Formerly a Portfolio Manager and Director of Gofen and Glossberg, Inc. He has 29 years investment experience Levy is a Chartered Financial Analyst charterholder.

INVESTMENT INFORMATION

Min Initial Investment:	$0
Min Initial Investment, IRA:	$0
Min Initial Investment, AIP:	NaN
Min Subsequent Investment:	$0
Min Subsequent Investment, IRA:	$0
Min Subsequent Investment, AIP:	N/A

MFVAX can be purchased from brokerages.

FUND SUMMARY

The investment seeks growth of capital over the long-term. The fund invests primarily in a nondiversified portfolio of U.S. equity securities. It focuses on companies with market capitalizations over $1 billion and which it believes have significant profit potential. The fund invests may invest up to 25% of the Fund?s total assets (valued at the time of investment) in securities of non-U.S. issuers. These may include foreign government obligations and foreign equity and debt securities that are traded over-the-counter or on foreign exchanges. It is nondiversified.

FUND OPERATIONS

Last Dividend (18-Dec-08):	0.12
Last Cap Gain (25-Aug-08):	0.55
Annual Holdings Turnover	43.00%
Average for Category:	78.74%

FEES & EXPENSES

Expense	MFVAX	Category Avg
Total Expense Ratio:	%	1.08%
Max 12b1 Fee:	%	N/A
Max Front End Sales Load:	5.75%	5.25%
Max Deferred Sales Load:	%	2.63%
3 Yr Expense Projection*:	$ YFT_NOT_APPLICABLE_ABBREVIATION	$781
5 Yr Expense Projection*:	$ YFT_NOT_APPLICABLE_ABBREVIATION	$1,299
10 Yr Expense Projection*:	$ YFT_NOT_APPLICABLE_ABBREVIATION	$2,389

* Per $10,000 invested

Add to Portfolio

Set Alert

Email to a Friend

•

Top Performers by Style

•

Morningstar Editorials